Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer
Hormonal therapy is the preferred systemic treatment for recurrent or metastatic, post-menopausal hormone-receptor-positive breast cancer. Previous studies have shown that there is no cross-resistance between exemestane and reversible aromatase inhibitors. Exposure to hormonal therapy does not hampe...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362023/ https://www.ncbi.nlm.nih.gov/pubmed/15856035 http://dx.doi.org/10.1038/sj.bjc.6602579 |
Search Result 1
Enlace del recurso
por Iaffaioli, R V, Formato, R, Tortoriello, A, Del Prete, S, Caraglia, M, Pappagallo, G, Pisano, A, Fanelli, F, Ianniello, G, Cigolari, S, Pizza, C, Marano, O, Pezzella, G, Pedicini, T, Febbraro, A, Incoronato, P, Manzione, L, Ferrari, E, Marzano, N, Quattrin, S, Pisconti, S, Nasti, G, Giotta, G, Colucci, G
Publicado 2005
Enlace del recurso
Publicado 2005
Enlace del recurso
Texto